about
Point-of-care assays for tuberculosis: role of nanotechnology/microfluidics.Crystal structure of human CD1e reveals a groove suited for lipid-exchange processesButyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cellsLigands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemiasFrom Immunologically Archaic to Neoteric Glycovaccines.Emerging technologies for monitoring drug-resistant tuberculosis at the point-of-careThe T-Cell Response to Lipid Antigens of Mycobacterium tuberculosisHigh-frequency and adaptive-like dynamics of human CD1 self-reactive T cells.Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver.A novel self-lipid antigen targets human T cells against CD1c(+) leukemiasAssistance of microbial glycolipid antigen processing by CD1e.Functional CD1a is stabilized by exogenous lipids.CD1a and MHC class I follow a similar endocytic recycling pathway.Early recycling compartment trafficking of CD1a is essential for its intersection and presentation of lipid antigens.Phosphoantigen Presentation to TCR γδ Cells, a Conundrum Getting Less Gray Zones.Endogenous phosphatidylcholine and a long spacer ligand stabilize the lipid-binding groove of CD1b.Self glycosphingolipids: new antigens recognized by autoreactive T lymphocytes.Fine tuning by human CD1e of lipid-specific immune responses.Structural reorganization of the antigen-binding groove of human CD1b for presentation of mycobacterial sulfoglycolipidsRecognition of lipid antigens by T cells.Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cellsHuman CD1-restricted T cell recognition of lipids from pollensDiacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with Mycobacterium tuberculosis.Mechanisms of lipid-antigen generation and presentation to T cells.How T lymphocytes recognize lipid antigens.MR1-restricted Valpha19i T cells: a second population recognizing lipid antigens?How T cells get grip on lipid antigens.Presentation of lipid antigens to T cells.The cellular and biochemical rules of lipid antigen presentation.How the immune system detects lipid antigens.Novel insights into lipid antigen presentation.T cells specific for lipid antigens.The Immunology of CD1- and MR1-Restricted T Cells.Functionally diverse human T cells recognize non-microbial antigens presented by MR1.Butyrophilin 3A (BTN3A, CD277)-specific antibody 20.1 differentially activates Vγ9Vδ2 TCR clonotypes and interferes with phosphoantigen activation.A semisynthetic carbohydrate-lipid vaccine that protects against S. pneumoniae in mice.IL-8-mediated angiogenic responses of endothelial cells to lipid antigen activation of iNKT cells depend on EGFR transactivation.Invariant natural killer T cells: linking inflammation and neovascularization in human atherosclerosis.Targeting leukemia by CD1c-restricted T cells specific for a novel lipid antigen.Cutting edge: a naturally occurring mutation in CD1e impairs lipid antigen presentation.
P50
Q27004505-64DCA791-4FB6-4A5A-B51B-FD3AE641CC68Q27671006-0173330C-A0F1-4E89-9C52-AFD145B96D7FQ27685257-B745DEC1-2E7C-4324-B5DF-99C74DF3C245Q28303057-5ABC5745-DC0F-492C-ACD9-3638CB80FA7DQ30238724-82CF87F4-93F4-43FB-8B27-BB542F723D3AQ30397647-E465DC00-F400-4853-8E7D-3F90B64E0FA2Q33658959-24B23576-AE9B-49EB-8BB2-B3C18C73B3F0Q33796925-F77E7136-2AA0-4B32-99CB-39A450B8D734Q33812840-A5370F89-09E9-4A8E-AE64-B8D88BDACCB4Q33826848-F7326ECC-39BC-4885-A4CD-D6E7A0BE13E9Q34470656-F0AFD393-0C9D-4784-9EDF-2A76B3E7FECFQ34566331-0D9DF7D5-8F37-4EE2-BE11-0E200D28D84AQ34593316-A444E5F4-321D-47B3-AC56-266600495D04Q34615077-8473268A-E414-489C-9675-4E4093AB7EFDQ34970077-1A3756AE-0663-4581-9B8C-33A8833C188BQ34972844-08C37B6B-8073-46D4-9A6B-6D7575588F73Q35088151-AAD21C93-0FB5-400E-8EB1-6CE030E3E412Q35180802-1E78A8CE-88E0-425E-BC56-FF69F959791CQ35470808-2649719A-796A-4800-941F-CD9A30A4BEF6Q36146922-70BAF8DA-1468-4DFD-ABDE-C7CE905C5A6BQ36370502-02331754-3796-4FA9-BC09-27F38FA0D429Q36403172-7C75034C-E7EF-4225-B5AD-2DFFE026ACF2Q36403863-A89B3FA3-83DB-4FF4-A985-0CA9E202EEFFQ36566989-6396914A-7541-45CC-BCB4-472075C6C1B5Q36584187-DB72DC51-8381-4290-984C-6BFD1385C2ADQ36857468-EDC36DB2-2C41-46CF-A1D9-086E0238E36CQ37027009-90137199-F353-4521-92A1-27D490D4F828Q37075019-B4059AD4-8319-4295-8C01-197A2D3994A2Q37591431-A28F85DA-89F4-458D-B0F4-16190CC44502Q37621622-33BC9E87-3392-4563-B192-0A80E8258780Q37985188-C1DB1764-2DAC-406F-93E7-30ED97E46216Q37994621-A7BEC185-0B59-404C-8608-EEA354E29F69Q38755146-8EC18E0E-D8F2-48F4-B76C-837C87A57D13Q38778174-8C69AE40-ED9F-4474-9E98-5C531F0E77DFQ38848635-FD469B7D-CDCE-443F-B24B-3B4BCCC8A907Q38950572-1B82F38C-AE23-47F7-B97C-B80F58AD5330Q39496836-6DF4DDEF-3DEB-41A8-8964-DBE9A39B58ACQ39634192-1182037E-133D-4CE1-B068-B84C1843C5D0Q39835296-DF1941A4-12B1-4BD9-B597-520360FC4EDBQ40004847-CEEE3089-D4A2-48F0-93A1-11AC7174D054
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gennaro De Libero
@ast
Gennaro De Libero
@en
Gennaro De Libero
@es
Gennaro De Libero
@nl
type
label
Gennaro De Libero
@ast
Gennaro De Libero
@en
Gennaro De Libero
@es
Gennaro De Libero
@nl
prefLabel
Gennaro De Libero
@ast
Gennaro De Libero
@en
Gennaro De Libero
@es
Gennaro De Libero
@nl
P1006
P214
P227
P244
P1006
P106
P21
P213
0000 0000 3866 9501
P214
P227
P244
n2009180224
P31
P496
0000-0003-0853-7868
P569
1957-01-01T00:00:00Z
P7859
lccn-n2009180224